Open Access

Authors
Publication date
Publisher

Abstract

YC-1 enhances the anti-tumor activity of sorafenib through inhibition of signal transducer and activator of transcription 3 (STAT3) in hepatocellular carcinom

    Similar works

    Full text

    thumbnail-image

    Available Versions

    CiteSeerX

    redirect
    oaioai:CiteSeerX.psu:10.1.1.434.3...
    Last time updated on 22/10/2014